Unknown

Dataset Information

0

Preclinical Studies of MSC-Derived Extracellular Vesicles to Treat or Prevent Graft Versus Host Disease: a Systematic Review of the Literature.


ABSTRACT: INTRODUCTION:Treating and preventing graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplant (HCT) remains a significant challenge. The use of mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) appears promising and a systematic review of preclinical studies is needed to accelerate the design of translational studies. METHODS:We identified 4 eligible studies from a systematic review performed on December 1, 2018. In brief, eligible studies included the treatment or prevention of GVHD in animal models and the use of MSC-EVs. Study design and outcome data were extracted and reporting was evaluated using the SYRCLE tool to identify potential bias. RESULTS:Two studies assessed the efficacy of MSC-EVs in treatment of GVHD and 2 studies address prevention. Mice treated with MSC-EVs showed improved median survival, GVHD clinical scores and histology scores as compared to untreated mice with GVHD. Prophylactic treatment with MSC-EVs attenuated GVHD severity and improved median survival as compared to no treatment or saline. CONCLUSION:Our systematic review provides important insight regarding the potential of MSC-EVs to treat or prevent GVHD. Although few studies were identified, improved survival and attenuated histologic findings of GVHD were observed in mice after MSC-EV administration for the treatment and prevention of GVHD. Dosing of EVs and route of administration remain inconsistent, however, and scalability of EV isolation for clinical studies remains a challenge. Standardized outcome reporting is needed to pool results for metanalysis. Graphical abstract.

SUBMITTER: Gupta M 

PROVIDER: S-EPMC7648545 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preclinical Studies of MSC-Derived Extracellular Vesicles to Treat or Prevent Graft Versus Host Disease: a Systematic Review of the Literature.

Gupta Manika M   Tieu Alvin A   Slobodian Mitchell M   Shorr Risa R   Burger Dylan D   Lalu Manoj M MM   Allan David S DS  

Stem cell reviews and reports 20201107 2


<h4>Introduction</h4>Treating and preventing graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplant (HCT) remains a significant challenge. The use of mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) appears promising and a systematic review of preclinical studies is needed to accelerate the design of translational studies.<h4>Methods</h4>We identified 4 eligible studies from a systematic review performed on December 1, 2018. In brief, eligible studies in  ...[more]

Similar Datasets

| S-EPMC5409787 | biostudies-literature
| S-EPMC7456225 | biostudies-literature
| S-EPMC6418480 | biostudies-literature
| S-EPMC8987226 | biostudies-literature
| S-EPMC8064883 | biostudies-literature
| S-EPMC7028690 | biostudies-literature
| S-EPMC9974012 | biostudies-literature
| S-EPMC7700340 | biostudies-literature
| S-EPMC6118599 | biostudies-literature